NYSE ARCA | ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments inU. S. and non-U.S. health care companies.
The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 8.98% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 8.63% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.95% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 5.61% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.49% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 5.09% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 4.77% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.17% |
| COO | The Cooper Companies, Inc | Healthcare | Medical Instruments & Supplies | 3.53% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.47% |
| 0QIU | Novo Nordisk A/S Class B | 3.37% | ||
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 3.35% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 2.83% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.69% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 2.66% |
| 7741 | Hoya Cor | Healthcare | Medical Instruments & Supplies | 2.66% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.53% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.51% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.46% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.45% |